JP1 was targeted to and entered melanoma cells with high expression of integrin αvβ3 by RGD, and then interacted with MEK1/2 to activate E3 ubiquitination enzyme NEDD4L, which accelerated the degradation of SP1 and ultimately played a transcriptional inhibitory role on integrin αvβ3. Here, SP1 is linked to melanoma.